J. Lloveras

发表

Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan.

D. Batlle, M. Soler, J. Wysocki, 2009, American journal of physiology. Renal physiology.

Putative endothelial progenitor cells are associated with flow‐mediated dilation in refractory hypertensives

A. de la Sierra, A. Oliveras, M. Larrousse, 2008, Blood pressure.

Insulin independence in type I diabetes after transplantation of unpurified islets from single donor with 15-deoxyspergualin

J. Najarian, J. Lloveras, P. Gores, 1993, The Lancet.

About “Low Mortality and Key Aspects of Delivery of Care for End-Stage Renal Disease in Italy”

J. Pascual, J. Lloveras, J. Portolé, 2009, TheScientificWorldJournal.

Usefulness of diltiazem in reducing the incidence of acute tubular necrosis in Euro-Collins-preserved cadaveric renal grafts.

A. Oliveras, J. Lloveras, J. Aubía, 1991, Transplantation proceedings.

Stroke in renal transplant recipients: epidemiology, predictive risk factors and outcome

A. Oliveras, M. Mir, J. Lloveras, 2003, Clinical transplantation.

Prolongation of canine islet allograft survival by 15-deoxyspergualin.

M. Field, D. Sutherland, D. Kaufman, 1992, Journal of Surgical Research.

Organ donors with adequately treated bacterial meningitis may be suitable for successful transplantation.

M. Mir, A. López-Navidad, J. Lloveras, 2000, Transplantation proceedings.

Ambulatory blood pressure monitoring in renal transplant patients: modifiable parameters after active antihypertensive treatment.

A. Oliveras, J. Lloveras, S. Vázquez, 2004, Transplantation proceedings.

Effect of time elapsed since transplantation on lipid and lipoprotein abnormalities in renal transplant patients: role of maintenance prednisone and gender influence.

A. Oliveras, M. Sentí, J. Lloveras, 1997, Transplantation proceedings.

Use of cyclosporine in renal transplantation.

J. Lloveras, 2004, Transplantation proceedings.

Barcelona document on organ procurement.

J. Lloveras, 1997, Transplantation proceedings.

Efficacy and safety of doxazosin GITS in hypertensive renal transplant patients: comparison of 8 and 4 mg.

A. Oliveras, J. Lloveras, S. Vázquez, 2003, Transplantation proceedings.

Posttransplant lymphoproliferative disease: treatment and outcome in renal transplant recipients.

A. Salar, M. Mir, J. Lloveras, 2003, Transplantation proceedings.

Introducing an informative program on donation and transplantation into secondary education.

A. Martínez‐Castelao, J. Vilardell, A. López-Navidad, 2002, Transplantation proceedings.

Victims of cyanide poisoning make suitable organ donors

X. Nogués, J. Lloveras, J. Aubía, 1996, Transplant international : official journal of the European Society for Organ Transplantation.

Survey of secondary education teachers in Catalonia on donation and transplants.

A. Martínez‐Castelao, J. Vilardell, A. López-Navidad, 1999, Transplantation proceedings.

Cadaver kidney transplantation in Catalonia: successful organization.

M. Viedma, J. Lloveras, J. Grinyó, 1999, Transplantation proceedings.

Treatment of gingival hyperplasia secondary to cyclosporine by the new macrolide azithromycin.

M. Mir, J. Lloveras, J. Masramon, 1997, Transplantation proceedings.

Heterotopic liver transplantation in a case of cirrhosis with portal vein thrombosis.

D. Durand, B. Pradère, J. Lloveras, 1990, Transplantation proceedings.

A Paired Survival Analysis Comparing Hemodialysis and Kidney Transplantation From Deceased Elderly Donors Older Than 65 Years

J. Pascual, M. Crespo, J. Lloveras, 2015, Transplantation.

Recurrence of IgA nephropathy and Henoch-Schönlein purpura after kidney transplantation: risk factors and graft survival.

M. Mir, J. Lloveras, S. Vázquez, 2005, Transplantation proceedings.

ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice.

D. Batlle, M. Soler, Y. Kanwar, 2007, Kidney international.

Intrathymic islet allografts prevent hyperglycemia and autoimmune beta-cell destruction in BB rats following transplantation in the prediabetic period.

J. Najarian, D. Sutherland, K. Brayman, 1993, Transplantation Proceedings.

Effect of cyclosporine on serum lipoprotein(a) levels in renal transplant recipients.

A. Oliveras, M. Sentí, M. Mir, 1997, Transplantation proceedings.

Circulating Endothelial Progenitor Cells After Kidney Transplantation

A. Oliveras, S. Vilaró, M. Soler, 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

De novo kidney transplant recipients need higher doses of Advagraf compared with Prograf to get therapeutic levels.

M. Mir, M. Crespo, J. Lloveras, 2009, Transplantation proceedings.

Survival Benefit From Kidney Transplantation Using Kidneys From Deceased Donors Aged ≥75 Years: A Time‐Dependent Analysis

J. Pascual, M. Pérez-Sáez, M. Crespo, 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Assessing the Limits in Kidney Transplantation: Use of Extremely Elderly Donors and Outcomes in Elderly Recipients

J. Pascual, J. Lloveras, E. Arcos, 2020, Transplantation.

The elderly donor.

J. Lloveras, 1991, Transplantation proceedings.

Endothelial progenitor cells are reduced in refractory hypertension

A. Oliveras, S. Vilaró, M. Soler, 2008, Journal of Human Hypertension.

Elderly and other suboptimal renal grafts and transplant outcome.

J. Lloveras, 1998, Transplantation proceedings.

Risk factors that influence the incidence and severity of MMF adverse events in renal transplant patients: relationship with corticosteroid dosage, renal function, sex, and patient age.

J. Manresa, M. Mir, J. Lloveras, 1999, Transplantation proceedings.

Prophylaxis with a short course of OKT3 in renal transplantation: comparative analysis with recipients treated either with prophylactic ATG or with CyA.

A. Oliveras, J. Lloveras, J. Aubía, 1992, Transplantation proceedings.

Disappearance of mesangial IgA deposits from the kidneys of two donors after transplantation.

M. Mir, J. Lloveras, J. Aubía, 1987, Transplantation proceedings.

Hepatitis C virus in renal transplantation.

A. Oliveras, M. Mir, J. Lloveras, 1991, Transplantation proceedings.

Transplantation of unpurified islets from single donors with 15-deoxyspergualin.

J. Najarian, D. Sutherland, J. Lloveras, 1994, Transplantation proceedings.

THE IN VIVO AND IN VITRO EFFECT OF 15‐DEOXYSPERGUALIN ON PANCREATIC ISLET FUNCTION

A. Farney, J. Lloveras, P. Gores, 1993, Transplantation.

Requirements for safe prednisone discontinuation in late renal transplantation in recipients immunosuppressed with cyclosporine.

M. Mir, J. Lloveras, J. Aubía, 1990, Transplantation proceedings.

Effect of cyclosporine A on normal human osteoblasts in vitro.

J. Lloveras, S. Serrano, M. Nácher, 1994, Bone and mineral.

Reflex sympathetic dystrophy syndrome of the lower limbs in a renal transplant patient treated with tacrolimus.

M. Mir, X. Perich, J. Lloveras, 2000, Transplantation.

Renal function in recipients of kidney allografts from elderly donors: a multicenter study.

J. Griño, P. Domingo, R. Deulofeu, 1988, Transplantation proceedings.

Five-year follow-up of 250 recipients of cadaveric kidney allografts from donors older than 55 years of age.

J. Morales, M. Arias, M. Mir, 1995, Transplantation proceedings.

Endothelial progenitor cells are reduced in refractory hypertension

A. Oliveras, J. Lloveras, S. Vázquez, 2008, Journal of Human Hypertension.

Long-term follow-up of recipients of cadaver kidney allografts from elderly donors.

M. Arias, M. Mir, R. Escallada, 1993, Transplantation proceedings.